The global macrolide drugs market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Macrolides are a class of antibiotics that includes erythromycin, roxithromycin, azithromycin and clarithromycin and are used in the treatment of respiratory, skin, soft tissue, sexually transmitted, H. pylori and atypical mycobacterial infections. The major factor for the growth of the market during the forecast period is the growing demand for antibiotics.
Get Free Sample link @ https://www.omrglobal.com/request-sample/macrolide-drugs-market
Additionally, the market is also growing owing to the rising prevalence of bacterial skin infections along with supportive government policies and legislation. Moreover, North America held the largest share in the market in 2020 owing to the well-developed healthcare infrastructure, increased R&D activities by the pharmaceutical companies as well as rapid adoption of new along with better healthcare technologies.
Some major players in the market include GlaxoSmithKline plc, Novartis AG, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in March 2018, Macrolide Pharmaceuticals announced that it received a CARB-X award of up to $6.8M to support the development of a novel fully synthetic, orally available macrolide antibiotic with Gram-negative activity, to treat serious infections including drug-resistant complicated urinary tract infections (cUTI).
Full report of Macrolide Drugs Market available @ https://www.omrglobal.com/industry-reports/macrolide-drugs-market
Market Coverage
- Segment Covered-
- By Drugs
- By Route of Administration
- By Infection
- By End-User
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- GlaxoSmithKline plc, Novartis AG, and Pfizer Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Macrolide Drugs Market Report by Segment
By Drugs
- Azithromycin
- Clarithromycin
- Erythromycin
- Fidaxomicin
- Telithromycin
By Route of Administration
- Oral
- Parenteral
By Infection
- Mycoplasma Pneumoniae
- Legionella SP
- Bordetella Pertussis
- Symptomatic Cat-Scratch Disease
- Bacillary angiomatosis
- Peliosishepatis
- Cerebral Toxoplasmosis
- Uncomplicated Skin Infections
By End-User
- Hospital
- Dermatology Clinic
- Ambulatory Center
- Research Laboratories
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/macrolide-drugs-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
